Uruguay

The population of Uruguay is predominantly urbanised, and suffers mainly from diseases associated with developed countries, such as cardiovascular disease and cancer.

Levels of tariff are high for both imported finished medicines and active ingredients.

Life expectancy at birth: 
75
Immunisation coverage among 1 year olds (%)
Measles: 
96
DTP3: 
94
HepB3: 
94
Hib3: 
94
Most recent tariff data
Year: 
2008
Weighted Average: 
9.49
Simple Average: 
8.68
Vaccines Year: 
2002
Vaccines: 
2.20
Old tariff data
Year: 
2002
Weighted Average: 
10.07
Simple Average: 
10.87